Oncologix Tech Inc. Reports Revenue Results Third Quarter and Nine Months Ending May 31, 2015
For the nine months, the company's revenues were $3,625,407, up from $2,696,776, an increase of 34% from the comparable periods in 2014.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | 0.00% | 0.00% | -92.00% |
2022 | DNAGO.Ai entered into a definitive business combination agreement to acquire Oncologix Tech, Inc. in a reverse merger transaction. | CI |
2016 | Oncologix Tech, Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-92.00% | 332K | |
+176.46% | 6.61B | |
+2.19% | 982M | |
+41.91% | 872M | |
+31.32% | 858M | |
+1.72% | 664M | |
+5.92% | 642M | |
-.--% | 600M | |
+3.61% | 503M | |
-.--% | 500M |